Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New WHO Reporting System for Lung Cytopathology to Enhance Diagnostic Accuracy

By LabMedica International staff writers
Posted on 13 Jun 2024

Lung cancer continues to be the most common cause of cancer-related deaths worldwide and ranks as the second most frequently diagnosed cancer in both men and women. More...

The role of lung cytopathology, which involves examining specimens such as sputum, bronchial brushings (BB), bronchial washings (BW), bronchoalveolar lavage (BAL), and fine needle aspiration biopsy (FNAB), is crucial for early and accurate diagnosis, thus enhancing treatment efficacy. The introduction of endobronchial ultrasound (EBUS) has significantly improved the diagnostic capabilities of FNAB by facilitating simultaneous diagnosis and staging. With the increasing significance of accurate lung tumor classification for molecular testing, there is a crucial need for the implementation of standardized terminology and reporting standards in lung cytopathology.

The World Health Organization (WHO, Geneva, Switzerland) has introduced a new reporting system designed to standardize this communication to enhance diagnostic accuracy, facilitate research, and encourage clinical trial participation. This system, the WHO Reporting System for Lung Cytopathology, developed in collaboration with the International Academy of Cytology (IAC, Freiburg im Breisgau, Germany) and the International Agency for Research on Cancer (IARC, Lyon, France), is the first of its kind aimed at standardizing the reporting of lung cytopathology specimens globally. It categorizes findings into five diagnostic categories—Insufficient/Inadequate/Non-diagnostic, Benign/Negative for Malignancy, Atypical, Suspicious for Malignancy, and Malignant. Each category is defined by specific cytomorphologic criteria, includes an estimated risk of malignancy (ROM), and offers guidelines for clinical management.

The WHO system provides specific clinical management recommendations for each diagnostic category. For instance, a diagnosis of "Malignant" often triggers further diagnostic actions such as bronchoscopy or imaging, possibly followed by EBUS- or CT-guided FNAB. Treatment may vary from surgical resection to systemic treatment, depending on the tumor's characteristics and condition of the patient. For benign results, ongoing monitoring and follow-up are generally recommended, while atypical or suspicious results may require additional testing to refine the diagnosis. The system also highlights the importance of ancillary tests like molecular and genetic testing, crucial for precise diagnoses and personalized treatment plans. These ancillary tests, including immunohistochemistry (IHC) and molecular assays, are critical for confirming diagnoses and are pivotal for identifying targeted therapies, particularly for lung adenocarcinoma and other specific cancer subtypes.

The WHO Reporting System for Lung Cytopathology is a pivotal step in achieving standardized, accurate, and effective lung cancer diagnostics. By providing distinct categories and criteria, it not only improves diagnostic consistency and patient management but also promotes ongoing research. The inclusion of ancillary testing and consideration for resource variability across different settings ensures that the system is applicable worldwide. Additionally, this standardization aids in gathering robust data for epidemiological studies and clinical trials, crucial for progressing our understanding and treatment of lung cancer. As this system becomes more widely adopted, it is expected to markedly enhance outcomes for lung cancer patients and contribute significantly to the global fight against this prevalent disease. Further refinement and research will continue to improve its clinical value and impact, maintaining its relevance in the field of lung cancer diagnostics.

Related Links:
WHO
IAC
IARC


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.